332 related articles for article (PubMed ID: 21862633)
1. Estrogen-dependent gene transcription in human breast cancer cells relies upon proteasome-dependent monoubiquitination of histone H2B.
Prenzel T; Begus-Nahrmann Y; Kramer F; Hennion M; Hsu C; Gorsler T; Hintermair C; Eick D; Kremmer E; Simons M; Beissbarth T; Johnsen SA
Cancer Res; 2011 Sep; 71(17):5739-53. PubMed ID: 21862633
[TBL] [Abstract][Full Text] [Related]
2. Proteasome inhibition represses ERalpha gene expression in ER+ cells: a new link between proteasome activity and estrogen signaling in breast cancer.
Powers GL; Ellison-Zelski SJ; Casa AJ; Lee AV; Alarid ET
Oncogene; 2010 Mar; 29(10):1509-18. PubMed ID: 19946334
[TBL] [Abstract][Full Text] [Related]
3. The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer.
Thaler S; Thiede G; Hengstler JG; Schad A; Schmidt M; Sleeman JP
Int J Cancer; 2015 Aug; 137(3):686-97. PubMed ID: 25530422
[TBL] [Abstract][Full Text] [Related]
4. The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-alpha and essential for the antiproliferative activity of ICI 182,780 in ERalpha-positive breast cancer cells.
Fan M; Bigsby RM; Nephew KP
Mol Endocrinol; 2003 Mar; 17(3):356-65. PubMed ID: 12554766
[TBL] [Abstract][Full Text] [Related]
5. Histone H2B monoubiquitination: roles to play in human malignancy.
Cole AJ; Clifton-Bligh R; Marsh DJ
Endocr Relat Cancer; 2015 Feb; 22(1):T19-33. PubMed ID: 24891457
[TBL] [Abstract][Full Text] [Related]
6. Intermittent hypoxia induces proteasome-dependent down-regulation of estrogen receptor alpha in human breast carcinoma.
Cooper C; Liu GY; Niu YL; Santos S; Murphy LC; Watson PH
Clin Cancer Res; 2004 Dec; 10(24):8720-7. PubMed ID: 15623657
[TBL] [Abstract][Full Text] [Related]
7. Roles of estrogen receptor and p21(Waf1) in bortezomib-induced growth inhibition in human breast cancer cells.
Maynadier M; Shi J; Vaillant O; Gary-Bobo M; Basile I; Gleizes M; Cathiard AM; Wah JL; Sheikh MS; Garcia M
Mol Cancer Res; 2012 Nov; 10(11):1473-81. PubMed ID: 22964432
[TBL] [Abstract][Full Text] [Related]
8. Loss of H2B monoubiquitination is associated with poor-differentiation and enhanced malignancy of lung adenocarcinoma.
Zhang K; Wang J; Tong TR; Wu X; Nelson R; Yuan YC; Reno T; Liu Z; Yun X; Kim JY; Salgia R; Raz DJ
Int J Cancer; 2017 Aug; 141(4):766-777. PubMed ID: 28481029
[TBL] [Abstract][Full Text] [Related]
9. The proteasome inhibitor bortezomib induces an inhibitory chromatin environment at a distal enhancer of the estrogen receptor-α gene.
Powers GL; Rajbhandari P; Solodin NM; Bickford B; Alarid ET
PLoS One; 2013; 8(12):e81110. PubMed ID: 24339902
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-101 Suppresses Tumor Cell Proliferation by Acting as an Endogenous Proteasome Inhibitor via Targeting the Proteasome Assembly Factor POMP.
Zhang X; Schulz R; Edmunds S; Krüger E; Markert E; Gaedcke J; Cormet-Boyaka E; Ghadimi M; Beissbarth T; Levine AJ; Moll UM; Dobbelstein M
Mol Cell; 2015 Jul; 59(2):243-57. PubMed ID: 26145175
[TBL] [Abstract][Full Text] [Related]
11. SUPT6H controls estrogen receptor activity and cellular differentiation by multiple epigenomic mechanisms.
Bedi U; Scheel AH; Hennion M; Begus-Nahrmann Y; Rüschoff J; Johnsen SA
Oncogene; 2015 Jan; 34(4):465-73. PubMed ID: 24441044
[TBL] [Abstract][Full Text] [Related]
12. Monoubiquitination of Histone H2B Blocks Eviction of Histone Variant H2A.Z from Inducible Enhancers.
Segala G; Bennesch MA; Pandey DP; Hulo N; Picard D
Mol Cell; 2016 Oct; 64(2):334-346. PubMed ID: 27692985
[TBL] [Abstract][Full Text] [Related]
13. let-7b and let-7c microRNAs promote histone H2B ubiquitylation and inhibit cell migration by targeting multiple components of the H2B deubiquitylation machinery.
Spolverini A; Fuchs G; Bublik DR; Oren M
Oncogene; 2017 Oct; 36(42):5819-5828. PubMed ID: 28604753
[TBL] [Abstract][Full Text] [Related]
14. The RING finger domain E3 ubiquitin ligases BRCA1 and the RNF20/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancer.
Dickson KA; Cole AJ; Gill AJ; Clarkson A; Gard GB; Chou A; Kennedy CJ; Henderson BR; ; Fereday S; Traficante N; Alsop K; Bowtell DD; deFazio A; Clifton-Bligh R; Marsh DJ
Hum Mol Genet; 2016 Dec; 25(24):5460-5471. PubMed ID: 27798111
[TBL] [Abstract][Full Text] [Related]
15. The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.
Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang
Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770
[TBL] [Abstract][Full Text] [Related]
16. The E3 ubiquitin ligase RNF40 suppresses apoptosis in colorectal cancer cells.
Schneider D; Chua RL; Molitor N; Hamdan FH; Rettenmeier EM; Prokakis E; Mishra VK; Kari V; Wegwitz F; Johnsen SA; Kosinsky RL
Clin Epigenetics; 2019 Jul; 11(1):98. PubMed ID: 31266541
[TBL] [Abstract][Full Text] [Related]
17. Genome wide transcriptional profiling in breast cancer cells reveals distinct changes in hormone receptor target genes and chromatin modifying enzymes after proteasome inhibition.
Kinyamu HK; Collins JB; Grissom SF; Hebbar PB; Archer TK
Mol Carcinog; 2008 Nov; 47(11):845-85. PubMed ID: 18381591
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
Zhao C; Matthews J; Tujague M; Wan J; Ström A; Toresson G; Lam EW; Cheng G; Gustafsson JA; Dahlman-Wright K
Cancer Res; 2007 Apr; 67(8):3955-62. PubMed ID: 17440111
[TBL] [Abstract][Full Text] [Related]
19. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
Lu W; Katzenellenbogen BS
Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
[TBL] [Abstract][Full Text] [Related]
20. The histone H2B ubiquitin ligase RNF40 is required for HER2-driven mammary tumorigenesis.
Wegwitz F; Prokakis E; Pejkovska A; Kosinsky RL; Glatzel M; Pantel K; Wikman H; Johnsen SA
Cell Death Dis; 2020 Oct; 11(10):873. PubMed ID: 33070155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
